This document is an excerpt from the EUR-Lex website
Document 62017TN0776
Case T-776/17: Action brought on 28 November 2017 — Medora Therapeutics v EUIPO — Biohealth Italia (LITHOREN)
Case T-776/17: Action brought on 28 November 2017 — Medora Therapeutics v EUIPO — Biohealth Italia (LITHOREN)
Case T-776/17: Action brought on 28 November 2017 — Medora Therapeutics v EUIPO — Biohealth Italia (LITHOREN)
IO C 63, 19.2.2018, p. 13–14
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
19.2.2018 |
EN |
Official Journal of the European Union |
C 63/13 |
Action brought on 28 November 2017 — Medora Therapeutics v EUIPO — Biohealth Italia (LITHOREN)
(Case T-776/17)
(2018/C 063/18)
Language in which the application was lodged: English
Parties
Applicant: Medora Therapeutics LTD (Halandri, Greece) (represented by: S. Santos Rodríguez, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Biohealth Italia Srl (Rivoli, Italy)
Details of the proceedings before EUIPO
Proprietor of the trade mark at issue: Applicant
Trade mark at issue: EU word mark ‘LITHOREN’ — EU trade mark No 12 744 901
Procedure before EUIPO: Proceedings for a declaration of invalidity
Contested decision: Decision of the Second Board of Appeal of EUIPO of 14 September 2017 in Case R 178/2017-2
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
order EUIPO to pay the costs, including those incurred in the proceedings before EUIPO. |
Pleas in law
|
— |
Infringement of Article 53(1)(a) of Regulation No 207/2009; |
|
— |
Infringement of Article 8(1)(b) of Regulation No 207/2009. |